What happens when you take metoprolol with melatonin?
Metoprolol is a beta-1 selective blocker prescribed for hypertension, angina, heart failure, post-heart-attack protection, and certain arrhythmias. The pineal gland in the brain depends on beta-1 adrenergic receptors to receive the nighttime signal from the sympathetic nervous system that triggers melatonin synthesis. Because metoprolol crosses into the brain and blocks beta-1 receptors throughout the body, it dampens that signal and suppresses endogenous melatonin production.
The result is the cluster of sleep complaints that metoprolol users commonly report: harder to fall asleep, lighter sleep with more awakenings, vivid or disturbing dreams, and morning fatigue. Studies of beta-blocker users show roughly a 50 percent reduction in urinary 6-sulfatoxymelatonin, the main melatonin metabolite, after several weeks of treatment. Oral melatonin taken at bedtime essentially replaces the hormone the drug has suppressed.
This is a pharmacological consequence of metoprolol's mechanism rather than a chemical clash. Melatonin does not change how metoprolol is absorbed or metabolized, and there is no evidence that supplemental melatonin reduces metoprolol's heart-rate or blood-pressure-lowering effect. You can take both safely. The question is whether your sleep needs the help.
Why is this important?
The 2012 randomized controlled trial by Scheer and colleagues in the journal SLEEP enrolled 16 hypertensive patients who had been on atenolol or metoprolol for at least one month and randomized them to 2.5 mg of immediate-release melatonin nightly or placebo for three weeks. The melatonin arm gained 36 minutes of total sleep time, improved sleep efficiency by 7.6 percentage points, and fell asleep 14 minutes faster on average. The benefits persisted briefly after stopping melatonin and there was no rebound insomnia.
This matters for two reasons. First, insomnia is one of the most common reasons people quit beta-blockers, and quitting suddenly can cause dangerous rebound hypertension, tachycardia, or ischemia. Keeping people on therapy with a low-dose supplement is preferable to switching to a less proven drug. Second, sleep deprivation itself raises blood pressure and cardiovascular risk; restoring sleep on metoprolol is a downstream cardiovascular win, not a tradeoff.
Melatonin also has a small independent blood-pressure-lowering effect, so it is mildly additive rather than antagonistic to metoprolol's intended action.
What should you do?
If your sleep has worsened since starting metoprolol and the change has lasted more than two weeks, discuss melatonin with your prescriber. The trial dose was 2.5 mg of immediate-release melatonin 30 to 60 minutes before bedtime. Many over-the-counter products start at 1 mg, and starting low is reasonable. Avoid high-dose 5 to 10 mg products as a first try; they often cause morning grogginess and can paradoxically disrupt deep sleep.
Time your metoprolol dose strategically when possible. If you are on once-daily extended-release metoprolol succinate (Toprol XL), morning dosing reduces overlap with the natural evening melatonin window. If you are on twice-daily metoprolol tartrate (Lopressor), the evening dose is harder to avoid; melatonin supplementation is then the most practical workaround.
Allow two to four weeks to judge whether melatonin is helping. If it does not, the sleep disruption may be driven by something other than melatonin deficiency, such as nightmares, sleep apnea unmasked by reduced sympathetic tone, or untreated anxiety. Persistent sleep problems on metoprolol warrant a focused sleep evaluation rather than escalating melatonin to large doses.
Do not stop metoprolol because of sleep problems without consulting your cardiologist. Abrupt withdrawal can cause rebound hypertension or ischemia, especially in patients with coronary disease.
Which specific products are affected?
Metoprolol is sold as Lopressor (immediate-release tartrate) and Toprol XL (extended-release succinate). The melatonin suppression effect is a class property of beta-blockers and varies with how much of the drug reaches the brain. Lipophilic beta-blockers including propranolol, metoprolol, and nebivolol suppress melatonin more strongly than hydrophilic ones like atenolol, though atenolol also has measurable effects because the pineal gland lies outside the strict blood-brain barrier.
Melatonin supplements vary widely in actual content. A 2017 analysis of 31 commercial products found actual doses ranging from 17 percent below to 478 percent above label claim. Look for USP-verified or NSF-certified products, or pharmacist-recommended brands. Choose immediate-release for sleep onset, extended-release only if your main problem is staying asleep. Avoid melatonin gummies, which often contain sugar and tend to be poorly standardized.
The bottom line
Metoprolol blocks the receptors that tell your pineal gland to make melatonin, so insomnia and vivid dreams are common side effects. Low-dose immediate-release melatonin, around 2.5 mg taken 30 to 60 minutes before bed, is a trial-supported way to restore sleep without compromising the cardiovascular benefits of metoprolol. Take metoprolol in the morning if your regimen allows, use a quality-verified low-dose product, and discuss the addition with your prescriber.